mesalamine has been researched along with thymoquinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campregher, C; Edelmann, W; Evstatiev, R; Gasche, C; Khare, V; Kortüm, B; Kucherlapati, MH; Lang, M; Mittlböck, M; Pinter, M; Scharl, T; Schmid, G | 1 |
1 other study(ies) available for mesalamine and thymoquinone
| Article | Year |
|---|---|
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Cell Proliferation; Colorectal Neoplasms, Hereditary Nonpolyposis; Disease Models, Animal; Female; Frameshift Mutation; HCT116 Cells; Humans; Intestinal Mucosa; Male; Mesalamine; Mice; Microsatellite Instability; Mutation Rate; MutS Homolog 2 Protein; Tumor Burden | 2015 |